Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19-Reference-Cited by-同舟云学术

Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19

Published:2012-05-30 Issue:9 Volume:40 Page:1698-1711
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Zvyaga Tatyana,Chang Shu-Ying,Chen Cliff,Yang Zheng,Vuppugalla Ragini,Hurley Jeremy,Thorndike Denise,Wagner Andrew,Chimalakonda Anjaneya,Rodrigues A. David

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference51 articles.

1. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes;Abelö;Drug Metab Dispos,2000

2. Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole;Andersson;Clin Pharmacol Ther,1990

3. Pharmacokinetic Studies with Esomeprazole, the (S)-Isomer of Omeprazole

4. Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies

5. Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15

2. Estimation of CDK inhibitors by RP-HPLC: application for pharmacokinetic interactions studies with PPIs;Bioanalysis;2024-07-17

3. An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?;Expert Opinion on Drug Metabolism & Toxicology;2024-07-15

4. Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?;Genes;2024-05-10

5. Suspected Hematuria: Adverse Effects of Rivaroxaban in Older Adult Treated for Atrial Fibrillation;Reports;2024-02-08